News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer
Mohammad Jad Moussa/X
Dec 22, 2024, 11:44

Mohammad Jad Moussa: Combining ICIs with Antiangiogenic Agents in Advanced Urothelial Cancer

Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, shared a post on X:

“Now in Bladder Cancer Journal of Bladder Cancer Advocacy Network.

Can Combining ICIs with Antiangiogenic Agents Revive Antiangiogenic Therapy in Advanced Urothelial Cancer?

1st Meta-Analysis: ORR 34% in ICI-naïve group vs 16% in ICI-exposed.

Better patient selection.”

Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis

Authors: Mohammad Jad Moussa, Iuliia Kovalenko, Emanuele Crupi, Ekaterina Proskuriakova, Yimin Geng, Giuseppe Fallara, Raed Benkhadra, Daniele Raggi, Matthew T. Campbell, Pavlos Msaouel, Omar Alhalabi

Mohammad Jad Moussa

Bladder Cancer Advocacy Network Bladder Cancer Journal cancer Daniele Raggi Ekaterina Proskuriakova Emanuele Crupi Giuseppe Fallara Iuliia Kovalenko Matthew T Campbell Mohammad Jad Moussa Omar Alhalabi OncoDaily Oncology patient selection Pavlos Msaouel Raed Benkhadra Yimin Geng
Special Coverage
Blog
Mar 29, 2025, 06:52
Foorquan Hashmi: A Journey of Learning, Growth and New Possibilities
Blog
Mar 29, 2025, 06:37
Alique Topalian: Reducing Your Risk Virtual Education Series
Blog
Mar 29, 2025, 06:23
UICC - The Growing Global Threat of Antimicrobial Resistance in Cancer Care
Blog
Mar 29, 2025, 06:05
Yat Man Tsang: Radiation therapists’ perspectives on AI
Insight
Mar 29, 2025, 06:01
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients
Blog
Mar 29, 2025, 04:55
Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM
Blog
Mar 29, 2025, 04:16
Maximilian Merz: From student to academic physician - A 14-Year Journey at MSKCC
OncoDaily Pulse
Mar 29, 2025, 03:34
OncoDaily partners with EYOC aiming for innovation, research and equitable care
Career
Mar 29, 2025, 03:20
Nasim Eftekhari: I've been promoted to Chief AI and Analytics Officer at City of Hope
Insight
Mar 28, 2025, 20:51
Samer Al Hadidi: Check out our recent work in Blood Advances, led by Bhavesh Mohan Lal at the UAMS Myeloma Center
Blog
Mar 28, 2025, 20:17
Mustafa H. Alsaadi: Excited to share that three of our abstracts have been accepted for poster presentation at ASCO 2025
Blog
Mar 28, 2025, 20:11
Raffaele Giusti: MARIPOSA overall survival data at ELCC25